Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.19B |
| 2 |
Microsoft
MSFT
|
+$1.07B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.06B |
| 4 |
Tesla
TSLA
|
+$1.01B |
| 5 |
Meta Platforms (Facebook)
META
|
+$691M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$689M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$525M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$450M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$305M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Financials | 9.02% |
| 3 | Communication Services | 7.25% |
| 4 | Consumer Discretionary | 6.95% |
| 5 | Healthcare | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
PUT
GSK
GSK
$104B
| $225K | ﹤0.01% |
4,720
| – | – |
|
3527
Frontier Group Holdings
ULCC
$1.53B
| $225K | ﹤0.01% |
14,230
+9,825
| +223% | +$152K |
|
3528
Veru
VERU
$36.1M
| $225K | ﹤0.01% |
2,632
+1,832
| +229% | +$145K |
|
3529
Mercantile Bank Corp
MBWM
$1.04B
| $224K | ﹤0.01% |
6,996
+4,952
| +242% | +$153K |
|
|
GTHX
3530
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $224K | ﹤0.01% |
16,725
+16,628
| +17,142% | +$271K |
|
3531
Braskem
BAK
$932M
| $223K | ﹤0.01% |
+10,213
| New | +$236K |
|
|
BRY
3532
DELISTED
Berry Corp
BRY
| $223K | ﹤0.01% |
30,874
+22,125
| +253% | +$131K |
|
|
PWOD
3533
DELISTED
Penns Woods Bancorp
PWOD
| $221K | ﹤0.01% |
9,243
-1,542
| -14% | -$36.6K |
|
3534
PUT
Starbucks
SBUX
$120B
| $221K | ﹤0.01% |
2,000
| – | – |
|
|
CMLS
3535
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $221K | ﹤0.01% |
18,065
+2,207
| +14% | +$26.6K |
|
3536
Dynagas LNG Partners
DLNG
$132M
| $220K | ﹤0.01% |
71,992
+7,192
| +11% | +$22.2K |
|
3537
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$275M
| $220K | ﹤0.01% |
4,444
-5,231
| -54% | -$281K |
|
3538
CALL
Hershey
HSY
$35.6B
| $220K | ﹤0.01% |
1,300
| – | – |
|
|
SCHW
3539
PUT
Charles Schwab
SCHW
$184B
| $220K | ﹤0.01% |
3,024
| – | – |
|
3540
CALL
Tilray
TLRY
$618M
| $220K | ﹤0.01% |
1,950
| – | – |
|
3541
Verastem
VSTM
$502M
| $220K | ﹤0.01% |
5,979
-54
| -0.9% | -$1.98K |
|
|
MARK
3542
DELISTED
Remark Holdings, Inc.
MARK
| $220K | ﹤0.01% |
20,927
+20,420
| +4,028% | +$267K |
|
|
CLVS
3543
DELISTED
Clovis Oncology, Inc.
CLVS
| $220K | ﹤0.01% |
49,339
+26,681
| +118% | +$129K |
|
3544
Goldman Sachs BDC
GSBD
$964M
| $219K | ﹤0.01% |
11,960
+11,116
| +1,317% | +$213K |
|
3545
PDS Biotechnology
PDSB
$37.9M
| $219K | ﹤0.01% |
+14,728
| New | +$184K |
|
3546
PUT
Centene
CNC
$30.9B
| $218K | ﹤0.01% |
3,500
| – | – |
|
|
DHIL
3547
DELISTED
Diamond Hill
DHIL
| $218K | ﹤0.01% |
1,241
+850
| +217% | +$149K |
|
|
DHF
3548
BNY Mellon High Yield Strategies Fund
DHF
$171M
| $218K | ﹤0.01% |
66,005
| – | – |
|
3549
CALL
Consolidated Edison
ED
$40.2B
| $218K | ﹤0.01% |
3,000
| – | – |
|
3550
iShares MSCI Intl Value Factor ETF
IVLU
$4.42B
| $218K | ﹤0.01% |
8,476
+8,364
| +7,468% | +$217K |
|
Similar funds
Barclays's Q3 2021 Portfolio in Review
As of Q3 2021, Barclays held 5,157 positions worth $222B, up 5% from $212B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $12.8B of net new capital in Q3 2021, opening 259 new positions and adding to 2,650 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street Technology Select Sector SPDR ETF, an estimated $689M trimmed.
- Barclays's largest Q3 2021 buy was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
- Barclays added most to Amazon in Q3 2021, an estimated $1.19B increase.
- Barclays's biggest Q3 2021 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $689M.
- Barclays fully exited GE Aerospace in Q3 2021, selling an estimated $248M.
- Barclays's ten largest holdings make up 31% of its $222B portfolio in Q3 2021.
- Barclays opened 259 new positions and closed 365 in Q3 2021.
- Barclays's portfolio value rose 5% quarter-over-quarter to $222B.
Based on Barclays's 13F filing for Q3 2021, filed 9 Nov 2021.